Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2010
03/18/2010WO2010031056A2 Methods and compositions for modulating ire1, src, and abl activity
03/18/2010WO2010030983A2 Pyrazole carboxamide inhibitors of factor xa
03/18/2010WO2010030722A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
03/18/2010WO2010030027A1 Aromatic nitrogen-containing 6-membered ring compounds and their use
03/18/2010WO2010029461A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/18/2010WO2010029457A2 An improved process for preparing losartan potassium
03/18/2010WO2010029299A1 Pyrimidinone derivaties for use as medicaments
03/18/2010WO2010028981A1 New benzimidazole derivatives
03/18/2010WO2010028974A1 Imidazole and triazole compounds, use thereof and agents containing said compounds
03/18/2010WO2010028862A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010WO2010028655A1 Isoquinolinone derivatives as nk3 antagonists
03/18/2010WO2010011949A3 Caprolactam monomers and copolymers made therefrom
03/18/2010WO2010010454A3 Crystalline forms of a 3-pyrrole substituted 2-indolinone malate salt
03/18/2010WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists
03/18/2010WO2009004164A9 Diazeniumdiolate derivatives, method for preparing same and pharmaceutical compositions containing same
03/18/2010US20100069648 Adamantane-Dipyrromethane Derivatives, Method Of Preparation And Applications In Anion Sensing
03/18/2010US20100069644 Method of regio-selective synthesis of tri-substituted-1, 2, 3-triazoles
03/18/2010US20100069636 Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which Have the Same
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069416 Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors
03/18/2010US20100069414 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/18/2010US20100069412 Phosphonoxy quinazoline derivatives and their pharmaceutical use
03/18/2010US20100069404 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
03/18/2010US20100069394 Fast-dissociating dopamine 2 receptor antagonists
03/18/2010US20100069391 Novel sEH Inhibitors and Their Use
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069353 Inhibitors of hiv replication
03/18/2010US20100069346 New Azetidine Derivatives as Neurokinin Receptor Antagonists for the Treatment of Gastrointestinal Diseases
03/18/2010US20100068197 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
03/18/2010US20100068176 Hepatitis c virus inhibitors
03/18/2010CA2737388A1 Methods and compositions for modulating ire1, src, and abl activity
03/18/2010CA2736970A1 Pyrimidinone derivatives for use as medicaments
03/18/2010CA2736370A1 Pyrazole carboxamide inhibitors of factor xa
03/18/2010CA2736295A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010CA2735369A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/18/2010CA2735184A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/18/2010CA2734034A1 New benzimidazole derivatives
03/18/2010CA2732612A1 Isoquinolinone derivatives as nk3 antagonists
03/17/2010EP2163553A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010EP2162442A1 Dual-acting benzoimidazole antihypertensive agents
03/17/2010EP2162441A2 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
03/17/2010EP2162436A1 Novel case of renin inhibitors
03/17/2010EP2162433A2 4' substituted compounds having 5-ht6 receptor affinity
03/17/2010EP2161994A2 Urotensin ii receptor antagonists
03/17/2010EP1347955B1 New mandelic acid derivatives and their use as throbin inhibitors
03/17/2010CN101675041A Aminopyrimidines useful as kinase inhibitors
03/17/2010CN101675036A dual-acting benzoimidazole antihypertensive agents
03/17/2010CN101671329A Indolylmaleimide compound substituted with 3-amino alcohol, preparation method and application thereof
03/17/2010CN101671310A Compounds and compositions useful as cathepsin s inhibitors
03/17/2010CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
03/17/2010CN101669952A Pyridazine derivatives and their use as therapeutic agents
03/16/2010US7678923 Method for synthesizing 5-chloro-1-aryl-4-(4,5-dicyano-1h-imidazol-2-yl)-3-alkyl-1h-pyrazole derivatives
03/16/2010US7678804 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678797 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
03/16/2010US7678474 Imidazole derivatives and organic electronic device using the same
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/11/2010WO2010028259A2 9-aminonoscapine and its use in treating cancers, including drug- resistant cancers
03/11/2010WO2010028254A2 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/11/2010WO2010028179A1 Heterocyclic compounds as gata modulators
03/11/2010WO2010028174A1 Novel biccyclic compounds as gata modulators
03/11/2010WO2010027181A2 Anthracene derivative and organic electroluminescence element using the same
03/11/2010WO2010026388A1 Isatin derivatives for use as in vivo imaging agents
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010WO2010026212A1 Novel inhibitors
03/11/2010WO2010026121A1 Bicyclic kinase inhibitors
03/11/2010WO2010026096A1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
03/11/2010WO2010026095A1 Novel benzamides, production thereof, and use thereof as medicaments
03/11/2010WO2010026087A1 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators
03/11/2010WO2010025856A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010WO2010025831A1 Heterocyclically substituted anilinopyrimidines as fungicides
03/11/2010WO2010025553A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010WO2010020432A8 Compounds for treatment of duchenne muscular dystrophy
03/11/2010WO2010011821A3 Dual-acting antihypertensive agents
03/11/2010WO2010007114A3 Heterocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors
03/11/2010WO2009158431A3 Pyrimidine derivatives as kinase inhibitors
03/11/2010WO2009143507A3 Silent desensitizers of neuronal nachr and methods of use thereof
03/11/2010WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
03/11/2010US20100063286 Piperazinyl-propyl-pyrazole derivatives as dopamine d4 receptor antagonists, and pharmaceutical compositions containing the same
03/11/2010US20100063285 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same
03/11/2010US20100063280 Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds
03/11/2010US20100063278 N-Formyl Hydroxylamines compounds
03/11/2010US20100063249 Proton-conducting compound and proton-conducting polymer
03/11/2010US20100063125 Melatonin derivatives and their use as antioxidants
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063076 Endothelin receptor antagonists
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063069 Gyrase inhibitors and uses thereof
03/11/2010US20100063064 3-(4-Fluoro-2-methyl-phenyl)-6-[5-methoxymethyl-4-(6-methoxy-pyridin-3-yl)-4H-[1,2,4]triazol-3-yl]-pyridazine; treatment of male sexual dysfunction, female sexual dysfunction, hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder, sexual pain disorder, or premature ejaculation
03/11/2010US20100063063 Substituted Heteroaryls
03/11/2010US20100063050 Novel heteropyrrole analogs acting on cannabinoid receptors
03/11/2010US20100063049 2-carbocycloamino-4-imidazolylpyrimidines as agents for the inhbition of cell proliferation
03/11/2010US20100063031 Kinase inhibitor compounds
03/11/2010US20100062972 Triazole compounds and uses related thereto
03/11/2010US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/11/2010US20100061982 3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
03/11/2010CA2735970A1 Isatin derivatives for use as in vivo imaging agents
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 626